• Orla Cullivan, Emma Roche, Mohammad Hegazy, Mohamed Taha, Garrett Durkan, Paddy O'Malley, Peter McCarthy, and Catherine M Dowling.
• Department of Urology, Galway University Hospital, Galway, Ireland. orla.cullivan@hse.ie.
• Ir J Med Sci. 2023 Feb 1; 192 (1): 273127-31.

BackgroundMultiparametric magnetic resonance imaging (mpMRI) has been increasingly recognised as an important tool in the diagnosis of prostate cancer. PI-RADSv2 guidelines recommend that important clinical information including prostate-specific antigen (PSA) levels, examination findings, and biopsy information should be included in mpMRI requests. PIRADS score and PSA density (PSAD) are both independent predictors for the presence of a clinically significant prostate cancer.AimsThis study aims to evaluate the quality of mpMRI requests and reports at our institution in accordance with these parameters.MethodsAll prostate mpMRIs performed by radiology services in Galway University Hospital between 1st September 2019 and 1st March 2020 were reviewed. Exclusion criteria were applied. Requests and reports were analysed for the presence of the following parameters: PSA-results, examination findings, biopsy information, PI-RADS score, prostate volume, and PSAD.ResultsA total of 586 mpMRIs were performed, and of these, 546 were included. PSA value was provided in 497 (91%) of requests, exam findings in 355 (65%), and biopsy information in 452 (82%). PIRADS score was included in 224 (41%) of reports, prostate volume in 178 (32.6%), and PSAD in 106 (19%).ConclusionsGreat variation in the quality of information contained in both requests and reports for prostate mpMRIs exists within our service. We aim to improve this by collaborating with our radiology colleagues to develop a proforma for requesting and reporting of mpMRIs for our radiology systems to ensure important clinical and radiological information is provided in future.© 2021. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.

17 keywords...

hide…